Research map: Intraductal carcinoma of the prostate does not independently predict adverse outcomes after radical prostatectomy: A National Cancer Database analysis

Back to the article

Papers in this map

  1. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours · Peter A. Humphrey · 2016 · 1981 citations · Cited by this paper
  2. Does size matter? A national analysis of patterns of adjuvant immunotherapy receipt and tumor size–dependent survival in pT3N0M0 clear cell renal cell carcinoma · 2026 · Related
  3. Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort · Dominique Trudel · 2014 · 194 citations · Cited by this paper
  4. Sex-based differences in peri-operative and long-term oncologic outcomes after primary surgical treatment for kidney cancer: A comprehensive analysis from a high-volume tertiary center · 2026 · Related
  5. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer · Pedro Isaacsson Velho · 2018 · 140 citations · Cited by this paper
  6. Universally offered germline testing in upper tract urothelial carcinoma · 2026 · Related
  7. Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories · Laura H. Porter · 2017 · 114 citations · Cited by this paper
  8. Automated algorithm for surgical outcomes abstraction for cystectomy · 2026 · Related
  9. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology · Daniel Eidelberg Spratt · 2025 · 114 citations · Cited by this paper
  10. Post-treatment diffusion MRI–derived apparent diffusion coefficient as a biomarker of response and prognosis following definitive radiotherapy for prostate cancer: Impact of focal dose escalation on ADC dynamics · 2026 · Related
  11. The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis · Noriyoshi Miura · 2020 · 51 citations · Cited by this paper
  12. Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC · 2026 · Related
  13. Population-based study of the incidence and survival for intraductal carcinoma of the prostate · Brian F. Dinerman · 2017 · 36 citations · Cited by this paper
  14. Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study · 2026 · Related
  15. Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes—Systematic Review and Meta-Analysis · Rafał Osiecki · 2023 · 30 citations · Cited by this paper
  16. Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study · 2026 · Related
  17. The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer‐specific survival · Vincent Quoc‐Huy Trinh · 2018 · 29 citations · Cited by this paper
  18. Featured SUO Fellow: Parth Thakker, MD · 2026 · Related
  19. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate · Jinge Zhao · 2021 · 28 citations · Cited by this paper
  20. Identification and validation of TP53/p53 status as a prognostic marker in penile squamous cell carcinoma: Evidence from a cohort study and meta-analysis · 2026 · Related
  21. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer · Pengfei Shen · 2019 · 24 citations · Cited by this paper
  22. The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate · Rajal B. Shah · 2025 · 19 citations · Cited by this paper
  23. Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy · Rihito Aizawa · 2022 · 13 citations · Cited by this paper
  24. Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through 18 F-DCFPyL‒Prostate-Specific Membrane Antigen‒Positron Emission Tomography/CT Scans in Pretreatment Prostate Cancer Patients · Rui Miguel Marques Bernardino · 2024 · 13 citations · Cited by this paper
  25. The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: Diagnostic accuracy of biopsy, MRI-visibility, and outcomes · Gaurav Pahouja · 2022 · 12 citations · Cited by this paper
  26. Intraductal Carcinoma of the Prostate: To Grade or Not to Grade · Jerasit Surintrspanont · 2023 · 10 citations · Cited by this paper
  27. Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management · Yibo Shi · 2024 · 10 citations · Cited by this paper
  28. Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable · Ying Wang · 2023 · 8 citations · Cited by this paper
  29. Prognostic value of intraductal carcinoma for adjuvant radiotherapy candidates after radical prostatectomy · Sedat Karakoc · 2021 · 7 citations · Cited by this paper
  30. The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis · Yucong Zhang · 2020 · 6 citations · Cited by this paper
  31. Associations Between Intraductal Prostate Cancer and Metastases Following Radical Prostatectomy in Men With Prostate Cancer in the Veterans Affairs Database · Tyler J. Nelson · 2023 · 5 citations · Cited by this paper
  32. Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer With and Without Synchronous Nodal Metastases at Radical Prostatectomy: Results From a Case-control Matched, Multicenter Study · Hilda A. de Barros · 2025 · 3 citations · Cited by this paper
  33. Intraductal Carcinoma of the Prostate With a Solid Nest Pattern May Be More Aggressive Than Gleason Grade 5 Conventional Prostatic Adenocarcinoma · Hangchuan Shi · 2025 · 3 citations · Cited by this paper
  34. Clinical Management of Intraductal Carcinoma of the Prostate · Gabriel Wasinger · 2024 · 2 citations · Cited by this paper
  35. The Blind Spot of Prostate-Specific Membrane Antigen Positron Emission Tomography Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer · David C. Chen · 2025 · 2 citations · Cited by this paper
  36. Evaluation of intraductal carcinoma and invasive cribriform carcinoma as predictors of genetic mutations in systemic treatment-naïve prostate cancer patients · Sangmin Lee · 2025 · 2 citations · Cited by this paper
  37. Molecular alteration profiles characterize intraductal carcinoma of the prostate · Harshitha Reddy Dudipala · 2025 · 2 citations · Cited by this paper
  38. A genomic classifier for prostate cancer correlates with adverse pathologic features: Transcriptomic features of cribriform and intraductal carcinoma of the prostate. · Zaeem M. Lone · 2022 · 1 citation · Cited by this paper
  39. Clinical implications of molecular alterations in intraductal carcinoma of the prostate. · Benjamin Miron · 2023 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)